Paper791682
The specific site of tunicamycin inhibition in the formation of dolichol-bound N-acetylglucosamine derivatives.
Lehle L and 1 other. FEBS Lett, 1976. Cited by 325 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The specific site of tunicamycin inhibition in the formation of dolichol-bound N-acetylglucosamine derivatives. Papers, record 791682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/791682
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The specific site of tunicamycin inhibition in the formation of dolichol-bound N-acetylglucosamine derivatives.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetylglucosamine | Major topic |
| Anti-Bacterial Agents | Major topic |
| Diterpenes | Major topic |
| Dolichols | Major topic |
| Glucosamine | Major topic |
| Organophosphorus Compounds | Major topic |
| Saccharomyces cerevisiae |
Source PubMed
Cited by99
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 325 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,212,382 | Activation of ATF3 via the integrated stress response pathway regulates innate immune response to restrict Zika virus. | J Virol | 2024 | https://conductscience.org/library/papers/39212382 | PubMed |
| 38,963,344 | Impaired myoblast differentiation and muscle IGF-1 receptor signaling pathway activation after N-glycosylation inhibition. | FASEB J | 2024 | https://conductscience.org/library/papers/38963344 | PubMed |
| 38,877,016 | Development of a natural product optimization strategy for inhibitors against MraY, a promising antibacterial target. | Nat Commun | 2024 | https://conductscience.org/library/papers/38877016 | PubMed |
| 37,546,954 | Activation of ATF3 via the Integrated Stress Response Pathway Regulates Innate Immune Response to Restrict Zika Virus. | bioRxiv | 2024 | https://conductscience.org/library/papers/37546954 | PubMed |
| 37,190,766 | Structure-Based Insight on the Mechanism of N-Glycosylation Inhibition by Tunicamycin. | Mol Cells | 2023 | https://conductscience.org/library/papers/37190766 | PubMed |
| 36,467,541 | Small molecule inhibitors of mammalian glycosylation. | Matrix Biol Plus | 2022 | https://conductscience.org/library/papers/36467541 | PubMed |
| 36,157,785 | Intermolecular Interactions of Nucleoside Antibiotic Tunicamycin with On-Target MraYCB-TUN and Off-Target DPAGT1-TUN in the Active Sites Delineated by Quantum Mechanics/Molecular Mechanics Calculations. | ACS Omega | 2022 | https://conductscience.org/library/papers/36157785 | PubMed |
| 34,373,586 | 3-Ketodihydrosphingosine reductase maintains ER homeostasis and unfolded protein response in leukemia. | Leukemia | 2022 | https://conductscience.org/library/papers/34373586 | PubMed |
| 33,429,911 | N-Glycosylation in Piroplasmids: Diversity within Simplicity. | Pathogens | 2021 | https://conductscience.org/library/papers/33429911 | PubMed |
| 33,404,015 | Identification and characterization of enzymes involved in the biosynthesis of pyrimidine nucleoside antibiotics. | Nat Prod Rep | 2021 | https://conductscience.org/library/papers/33404015 | PubMed |
| 32,877,278 | Endoplasmic reticulum stress causes insulin resistance by inhibiting delivery of newly synthesized insulin receptors to the cell surface. | Mol Biol Cell | 2020 | https://conductscience.org/library/papers/32877278 | PubMed |
| 32,743,134 | Priming and elongation of chitin chains: Implications for chitin synthase mechanism. | Cell Surf | 2019 | https://conductscience.org/library/papers/32743134 | PubMed |
| 30,608,666 | Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis. | Chem Rev | 2019 | https://conductscience.org/library/papers/30608666 | PubMed |
| 29,459,785 | GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation. | Nat Struct Mol Biol | 2018 | https://conductscience.org/library/papers/29459785 | PubMed |
| 29,209,212 | Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction. | Front Pharmacol | 2017 | https://conductscience.org/library/papers/29209212 | PubMed |
| 29,042,410 | H+ and Pi Byproducts of Glycosylation Affect Ca2+ Homeostasis and Are Retrieved from the Golgi Complex by Homologs of TMEM165 and XPR1. | G3 (Bethesda) | 2017 | https://conductscience.org/library/papers/29042410 | PubMed |
| 28,027,591 | TM6SF2 rs58542926 impacts lipid processing in liver and small intestine. | Hepatology | 2017 | https://conductscience.org/library/papers/28027591 | PubMed |
| 26,496,683 | XBP1s Links the Unfolded Protein Response to the Molecular Architecture of Mature N-Glycans. | Chem Biol | 2015 | https://conductscience.org/library/papers/26496683 | PubMed |
| 24,742,667 | Protein N-glycosylation in oral cancer: dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signaling. | Glycobiology | 2014 | https://conductscience.org/library/papers/24742667 | PubMed |
| 24,233,741 | Cell-cycle arrest of plant suspension cultures by tunicamycin. | Planta | 1986 | https://conductscience.org/library/papers/24233741 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/791682
GET https://conductscience.org/api/papers/v1/791682/cited_by?page=2